Mode
Text Size
Log in / Sign up
N/A N=147,716

Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke

Ischemic Stroke

Enrolled (actual)
147,716
Serious AEs
Results posted
Jan 2017
Primary outcome: Primary: Number of Participants Receiving Inpatient, Home, or Community Based Rehabilitation Services — 76720; 32350 participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
retrospective analysis (Other)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Duke University
Primary completion
May 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Receiving Inpatient, Home, or Community Based Rehabilitation Services
76720; 32350
PRIMARY
Home-time
271.2; 195.5
SECONDARY
Number of Participants Who Were Functionally Dependent or Dead 12 Months After Hospital Discharge
203; 77
SECONDARY
Quality of Life (QOL)
0.76; 0.68
SECONDARY
Number of Participants Who Were Institutionalized in a Nursing Home for Long-term Care Within 12 Months of Hospital Discharge.
64; 60
SECONDARY
Number of Participants Who Were Rehospitalized or Died Within 12 Months of Stroke Hospitalization.
18884; 23411
SECONDARY
Number of Participants Who Died Within 12 Months of Stroke Hospitalization
6221; 13274

Summary

Retrospective analysis of Get With the Guidelines-Stroke data linked with Medicare claims and the AVAIL longitudinal data sets to assess patterns, predictors, and outcomes associated with the use of rehabilitation services following hospitalization for ischemic stroke. Primary completion defined as the end of primary analyses, consistent with the end of the PCORI Cycle I grant period. Study completion defined as acceptance of final research report and lay abstract by PCORI.

Eligibility Criteria

Inclusion Criteria

  • acute ischemic stroke within the Get With the Guidelines-Stroke data set for 2006-2008, and successfully linked to Medicare claims through 2009

Exclusion Criteria

  • death during index hospitalization
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02284165). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search